FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37877411000001102: Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
538861000001118 Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
538871000001111 Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Has excipient Benzyl alcohol false Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Is a Atovaquone 750mg/5ml oral suspension sugar free true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Atovaquone true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) 250 ml Has AMP True Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start